Back to the Blog

RegeneSlim Recall (2014): DMAA and the 2017 Expansion

Published by

Originally published August 30, 2014. Restored and updated November 18, 2026. This article covers a historical recall and includes updated official safety information.

RegeneSlim’s 2014 recall concerned DMAA in appetite-control capsules sold by Regeneca Worldwide, a division of VivaCeuticals. A broader recall followed in 2017. Both events are historical.

The 2014 notice

The original blog notice described green-and-white sachets containing two capsules. Its expanded recall list named lots 823230415, EX0616R15813, EX0616R15814 and 11414RE5516.

A subsequent federal complaint describes FDA laboratory findings of DMAA in those lots and an additional lot. That document is a legal complaint; the four codes above preserve the scope of our original notice rather than serving as a complete list of every later affected product.

The broader 2017 recall

The March 8, 2017 company announcement hosted by FDA covered Regeneca’s entire herbal and dietary supplement line manufactured and sold between June 1, 2011 and February 8, 2017, including RegeneSlim. It included all lot numbers within that scope.

FDA now marks that later recall completed and terminated. This describes the recall’s administrative status; it is not a statement that leftover recalled capsules are safe to use.

Safety information and reporting

FDA advises consumers not to buy or use supplements containing DMAA. It can raise blood pressure and cause cardiovascular and other serious problems.

Do not use old recalled stock. Contact a healthcare professional about symptoms or concerns after use. FDA’s DMAA guidance links to its safety-reporting route. Keep the product label and lot code available when reporting a problem. This article does not confirm a currently operating refund or exchange program.

Comments are subject to moderation. Please keep private contact details, account numbers, and passwords out of comments. Read our Commenting Policy.

Leave a Reply

Your email address will not be published. Required fields are marked *